Diagnosis of malignant glioma: role of neuropathology (Q48961381)

17 February 2018

title

Diagnosis of malignant glioma: role of neuropathology (English)

1 reference

17 February 2018

Jeffrey J Olson

1 reference

17 February 2018

author name string

Daniel J Brat

series ordinal

1 reference

17 February 2018

Richard A Prayson

series ordinal

1 reference

17 February 2018

Timothy C Ryken

series ordinal

1 reference

17 February 2018

publication date

20 August 2008

1 reference

17 February 2018

Journal of Neuro-Oncology

published in

1 reference

17 February 2018

volume

1 reference

17 February 2018

issue

1 reference

17 February 2018

page(s)

287-311

1 reference

17 February 2018

Malignant glioma physiology: cellular response to hypoxia and its role in tumor progression

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9618-1

Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and grading

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9618-1

Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: A report of radiation therapy oncology group 83-02

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9618-1

High diagnostic accuracy of cytologic smears of central nervous system tumors. A 15-year experience based on 4,172 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9618-1

Squash preparation and frozen section in intraoperative diagnosis of central nervous system tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9618-1

Cell proliferation and tumors of the central nervous system, part II: radiolabeling, cytometric, and immunohistochemical techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9618-1

Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9618-1

Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9618-1

Impact of genotype and morphology on the prognosis of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9618-1

Small cell architecture--a histological equivalent of EGFR amplification in glioblastoma multiforme?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-008-9618-1

Diagnostic synergy in radiology and surgical neuropathology: neuroimaging techniques and general interpretive guidelines

21 January 2018

1 reference

12 December 2020

Grading of astrocytomas. A simple and reproducible method.

1 reference

12 December 2020

Intermediate filament expression in astrocytic neoplasms

1 reference

12 December 2020

Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas.

1 reference

12 December 2020

Necrosis as a prognostic factor in glioblastoma multiforme

1 reference

12 December 2020

Reliability of histological diagnosis including grading in gliomas biopsied by image-guided stereotactic technique

1 reference

12 December 2020

Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis

1 reference

12 December 2020

The presence of necrosis and/or microvascular proliferation does not influence survival of patients with anaplastic oligodendroglial tumours: review of 98 patients

1 reference

12 December 2020

Keratin expression in astrocytomas: an immunofluorescent and biochemical reassessment

1 reference

12 December 2020

Prognosis research: toward evidence-based results and a Cochrane methods group

1 reference

12 December 2020

Guidelines for the management of severe head injury. Brain Trauma Foundation

1 reference

12 December 2020

Mechanisms of disease: genetic predictors of response to treatment in brain tumors

1 reference

12 December 2020

Observer reliability in histological grading of astrocytoma stereotactic biopsies

1 reference

12 December 2020

Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients.

1 reference

12 December 2020

Clinical significance of EGFR amplification and the aberrant EGFRvIII transcript in conventionally treated astrocytic gliomas.

1 reference

12 December 2020

Primer: an evidence-based approach to prognostic markers

1 reference

12 December 2020

Oligodendroglioma. Histologic evaluation and prognosis.

1 reference

12 December 2020

Interobserver reproducibility among neuropathologists and surgical pathologists in fibrillary astrocytoma grading.

1 reference

12 December 2020

Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p

1 reference

12 December 2020

Proteomic analysis of cerebrospinal fluid discriminates malignant and nonmalignant disease of the central nervous system and identifies specific protein markers

1 reference

12 December 2020

Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials

1 reference

12 December 2020

Frozen section interpretation in surgical neuropathology. II. Intraspinal lesions

1 reference

12 December 2020

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

1 reference

12 December 2020

Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype

1 reference

12 December 2020

Use of MIB-1 (Ki-67) Immunoreactivity in Differentiating Grade II and Grade III Gliomas

1 reference

12 December 2020

Immunohistochemistry in melanocytic proliferative lesions

1 reference

12 December 2020

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

1 reference

12 December 2020

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

1 reference

12 December 2020

Attractin is elevated in the cerebrospinal fluid of patients with malignant astrocytoma and mediates glioma cell migration.

1 reference

12 December 2020

Alterations in molecular pathways of diffusely infiltrating glial neoplasms: application to tumor classification and anti-tumor therapy (Review).

1 reference

12 December 2020

Gene amplification as a prognostic factor in primary brain tumors

1 reference

12 December 2020

CT-assisted stereotactic brain biopsy: value of intraoperative frozen section diagnosis

1 reference

12 December 2020

Phase II trial of gefitinib in recurrent glioblastoma

1 reference

12 December 2020

Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance

1 reference

12 December 2020

The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors.

1 reference

12 December 2020

Mixed oligoastrocytomas: a survival and prognostic factor analysis

1 reference

12 December 2020

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas

1 reference

12 December 2020

Keratin intermediate filament expression in astrocytic neoplasms: analysis by immunocytochemistry, western blot, and northern hybridization

1 reference

12 December 2020

1 reference

12 December 2020

Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients.

1 reference

12 December 2020

The 2007 WHO classification of tumours of the central nervous system

1 reference

12 December 2020

In vitro drug response and molecular markers associated with drug resistance in malignant gliomas.

1 reference

12 December 2020

Mitosis identification in diffuse gliomas: implications for tumor grading

1 reference

12 December 2020

Accuracy of the smear technique in the cytological diagnosis of 650 lesions of the central nervous system

1 reference

12 December 2020

Quality of randomized controlled trials reporting in the primary treatment of brain tumors

1 reference

12 December 2020

PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.

1 reference

12 December 2020

Clarifying the diffuse gliomas: an update on the morphologic features and markers that discriminate oligodendroglioma from astrocytoma

1 reference

12 December 2020

Stereotactic brain biopsies: specimen preparation and evaluation

1 reference

12 December 2020

Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas.

1 reference

12 December 2020

Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas

1 reference

12 December 2020

An immunocytochemical comparison of glial fibrillary acidic protein, S-100p and vimentin in human glial tumors

1 reference

12 December 2020

Role of MIB1 in predicting survival in patients with glioblastomas

1 reference

12 December 2020

Epidermal growth factor receptor gene amplification as a prognostic marker in glioblastoma multiforme: results of a meta-analysis

1 reference

12 December 2020

O6-methylguanine-DNA methyltransferase expression strongly correlates with outcome in childhood malignant gliomas: results from the CCG-945 Cohort

1 reference

12 December 2020

Interobserver variability associated with the MIB-1 labeling index: high levels suggest limited prognostic usefulness for patients with primary brain tumors.

1 reference

12 December 2020

Update on central nervous system cytopathology. II. Brain smear technique.

1 reference

12 December 2020

Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics

1 reference

12 December 2020

Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.

1 reference

12 December 2020

Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma. A study of paraffin-embedded sections

1 reference

12 December 2020

Identification of human brain tumour initiating cells

1 reference

12 December 2020

Clinicopathologic aspects of 1p/19q loss and the diagnosis of oligodendroglioma

1 reference

12 December 2020

Small cell astrocytoma: An aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma

1 reference

12 December 2020

Touch preparations in the rapid intraoperative diagnosis of central nervous system lesions. A comparison with frozen sections and paraffin-embedded sections

1 reference

12 December 2020

Supratentorial gliomas: a comparative study by grade and histologic type.

1 reference

12 December 2020

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

1 reference

12 December 2020

Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies

1 reference

12 December 2020

A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor.

1 reference

12 December 2020

Use of cytological preparations in the frozen section diagnosis of central nervous system neoplasia

1 reference

12 December 2020

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

1 reference

12 December 2020

Prognostic implications of glial fibrillary acidic protein containing cell types in oligodendrogliomas

1 reference

12 December 2020

An interdisciplinary approach to avoid the overtreatment of patients with central nervous system lesions

1 reference

12 December 2020

Use of cytological preparations for the intraoperative diagnosis of stereotactically obtained brain biopsies: a 19-year experience and survey of neuropathologists

1 reference

12 December 2020

Imprints, smears, and frozen sections of brain tumors

1 reference

12 December 2020

The Prognostic Significance of Ki-67 Labeling Indices for Oligodendrogliomas

1 reference

12 December 2020

Clinicopathologic correlations in the oligodendroglioma.

1 reference

12 December 2020

Prediction of central nervous system embryonal tumour outcome based on gene expression

1 reference

12 December 2020

Evaluation of epithelial and keratin markers in glioblastoma multiforme: an immunohistochemical study

1 reference

12 December 2020

Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas

1 reference

12 December 2020

Frozen section evaluation of stereotactic brain biopsies: diagnostic yield at the stereotactic target position in 188 cases

1 reference

12 December 2020

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

12 December 2020

Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.

1 reference

12 December 2020

Glial fibrillary acidic protein (GFAP) in oligodendroglial tumors: gliofibrillary oligodendroglioma and transitional oligoastrocytoma as subtypes of oligodendroglioma.

1 reference

12 December 2020

Diagnostic synergy in radiology and surgical neuropathology: radiographic findings of specific pathologic entities

1 reference

12 December 2020

Cellular proliferation in pilocytic and diffuse astrocytomas

1 reference

12 December 2020

Structural alterations of the epidermal growth factor receptor gene in human gliomas

1 reference

12 December 2020

Prognostic implication of histopathological, immunohistochemical and clinical features of oligodendrogliomas: a study of 89 cases.

1 reference

12 December 2020

Accuracy of grading gliomas on CT-guided stereotactic biopsies: A survival analysis

1 reference

12 December 2020

Reporting recommendations for tumor marker prognostic studies (REMARK).

1 reference

12 December 2020

Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.

1 reference

12 December 2020

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

12 December 2020

A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters

1 reference

12 December 2020

Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas.

1 reference

12 December 2020

Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib

1 reference

12 December 2020

Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results

1 reference

12 December 2020

Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.

1 reference

12 December 2020

Low-grade glioma: supratentorial astrocytoma, oligodendroglioma, and oligoastrocytoma in adults

1 reference

12 December 2020

10.1007/S11060-008-9618-1

Identifiers

DOI

1 reference

17 February 2018

1 reference

17 February 2018